2D-LC-MS improves peptide impurity profiling by enabling salt-based eluents, detecting co-eluting isomers, and solving challenges with shifting retention times.

MD-LC-MS advances structural and functional analysis of mAbs, showing how post-translational changes impact FcRn/FcγR binding and antibody therapeutic performance.

We explore open-source LC×LC-HRMS workflows for non-target screening, highlighting variable selection and curve-resolution to improve trace-level compound detection.

This study introduces a 2D-LC-MS method for AAV characterization, integrating SEC and RP-LC-MS to analyze HMWs, viral proteins, and PTMs, improving gene therapy vector assessment.

This week we bring you applications by Shimadzu, Metrohm, and Waters Corporation, a presentation by Agilent Technologies, and a poster from MSACL by Thermo Fisher Scientific!

This week we bring you applications, presentations, and posters by Metrohm, Thermo Fisher Scientific, Shimadzu, Waters Corporation, and Agilent Technologies!

We bring you posters, presentations, applications, and other documents by Thermo Fisher Scientific, Agilent Technologies, Shimadzu, Waters Corporation, and James Little Mass Spec Interpretation Services!

The central question addressed in the presentation was “What do we know about (your) antibodies?”, highlighting how innovative techniques in mass spectrometry provide novel insights.

This week we bring to you applications by Shimadzu, Thermo Fisher Scientific, Agilent Technologies, and presentation by James Little Mass Spec Interpretation Services!

This year, Karel Šmejkal received the MU Rector’s Award for long-term excellence in research in the field of natural sciences and medicine.